Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity

Nutrition Journal

Volumn 14, Issue 1, 2015, Pages

  Drouin Chartier, Jean Philippe ^a   Gagnon, Josée ^a   Labonté, Marie Ève ^a   Desroches, Sophie ^a   Charest, Amélie ^a   Grenier, Geneviève ^a   Dodin, Sylvie ^a   Lemieux, Simone ^a   Couture, Patrick ^a   Lamarche, Benoît ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Blood pressure; Cardiovascular disease; Dairy; Metabolic syndrome; Milk; Postmenopausal women; Randomized controlled study

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CARBOHYDRATE; CELL ADHESION MOLECULE; CHOLESTEROL; ENDOTHELIN; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; STEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HEALTH IMPACT ASSESSMENT; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID HOMEOSTASIS; LIPOLYSIS; LOW FAT DIET; MACRONUTRIENT; METABOLIC SYNDROME X; MILK; POSTMENOPAUSE; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THERAPY EFFECT; TREATMENT DURATION; ANIMAL; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPLICATION; DAIRY PRODUCT; DIET; FEEDING BEHAVIOR; INSULIN RESISTANCE; MIDDLE AGED; PATHOPHYSIOLOGY; WAIST CIRCUMFERENCE;

AGED; ANIMALS; APOLIPOPROTEINS B; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-OVER STUDIES; DAIRY PRODUCTS; DIET; FEMALE; FOOD HABITS; HUMANS; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS, VLDL; METABOLIC SYNDROME X; MIDDLE AGED; MILK; OBESITY, ABDOMINAL; POSTMENOPAUSE; RISK FACTORS; STEROLS; WAIST CIRCUMFERENCE;

EID: 84964694014     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-14-12     Document Type: Article

References (58)

1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769-78.
2. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis. 2010;20:140-6.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
4. Chan DC, Barrett PH, Watts GF. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol. 2006;17:28-36.
5. Gylling H, Hallikainen M, Kolehmainen M, Toppinen L, Pihlajamaki J, Mykkanen H, et al. Cholesterol synthesis prevails over absorption in metabolic syndrome. Transl Res. 2007;149:310-6.
6. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33:351-75.
7. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375:181-3.
8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
9. Yoo S, Nicklas T, Baranowski T, Zakeri IF, Yang SJ, Srinivasan SR, et al. Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: the Bogalusa Heart Study. Am J Clin Nutr. 2004;80:841-8.
10. Davy BM, Melby CL. The effect of fiber-rich carbohydrates on features of Syndrome X. J Am Diet Assoc. 2003;103:86-96.
11. Freire RD, Cardoso MA, Gimeno SG, Ferreira SR. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 2005;28:1779-85.
12. Pereira MA, Jacobs Jr DR, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002;287:2081-9.
13. Shin H, Yoon YS, Lee Y, Kim CI, Oh SW. Dairy product intake is inversely associated with metabolic syndrome in Korean adults: Anseong and Ansan cohort of the Korean Genome and Epidemiology Study. J Korean Med Sci. 2013;28:1482-8.
14. Ralston RA, Lee JH, Truby H, Palermo CE, Walker KZ. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J Hum Hypertens. 2012;26:3-13.
15. Soedamah-Muthu SS, Verberne LD, Ding EL, Engberink MF, Geleijnse JM. Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension. 2012;60:1131-7.
16. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One. 2013;8:e73965.
17. Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr. 2011;65:1027-31.
18. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr. 2013;98:1066-83.
19. Rossouw JE, Burger EM, Van der Vyver P, Ferreira JJ. The effect of skim milk, yoghurt, and full cream milk on human serum lipids. Am J Clin Nutr. 1981;34:351-6.
20. Hilary Green J, Richards JK, Bunning RL. Blood pressure responses to high-calcium skim milk and potassium-enriched high-calcium skim milk. J Hypertens. 2000;18:1331-9.
21. Soerensen KV, Thorning TK, Astrup A, Kristensen M, Lorenzen JK. Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am J Clin Nutr. 2014;99:984-91.
22. Hussi E, Miettinen TA, Ollus A, Kostiainen E, Ehnholm C, Haglund B, et al. Lack of serum cholesterol-lowering effect of skimmed milk and butter milk under controlled conditions. Atherosclerosis. 1981;39:267-72.
23. Buonopane GJ, Kilara A, Smith JS, McCarthy RD. Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides in a free-living human population. J Am Coll Nutr. 1992;11:56-67.
24. Hidaka H, Takiwaki M, Yamashita M, Kawasaki K, Sugano M, Honda T. Consumption of nonfat milk results in a less atherogenic lipoprotein profile: a pilot study. Ann Nutr Metab. 2012;61:111-6.
25. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
26. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J. 2004;3:13.
27. Flood A, Subar AF, Hull SG, Zimmerman TP, Jenkins DJ, Schatzkin A. Methodology for adding glycemic load values to the National Cancer Institute Diet History Questionnaire database. J Am Diet Assoc. 2006;106:393-402.
28. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76:5-56.
29. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993;17:187-96.
30. Richard C, Couture P, Desroches S, Charest A, Lamarche B. Effect of the Mediterranean diet with and without weight loss on cardiovascular risk factors in men with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2011;21:628-35.
31. An P, Rice T, Gagnon J, Borecki IB, Bergeron J, Despres JP, et al. Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program: the HERITAGE Family Study. Arterioscler Thromb Vasc Biol. 2000;20:807-14.
32. Lamarche B, St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Despres JP. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol. 2001;17:859-65.
33. Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Despres JP, et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med. 2001;161:2474-80.
34. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens. 2001;14:44S-54S.
35. Labonte ME, Couture P, Paquin P, Chouinard Y, Lemieux S, Lamarche B. Comparison of the impact of trans fatty acids from ruminant and industrial sources on surrogate markers of cholesterol homeostasis in healthy men. Mol Nutr Food Res. 2011;55 Suppl 2:S241-7.
36. Simonen P, Gylling H, Miettinen TA. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis. 2008;197:883-8.
37. Richterich R, Dauwalder H. [Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method]. Schweiz Med Wochenschr. 1971;101:615-8.
38. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971;33:732-8.
39. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95.
40. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract. 1990;10:167-75.
41. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70.
42. Desroches S, Paradis ME, Perusse M, Archer WR, Bergeron J, Couture P, et al. Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet. J Lipid Res. 2004;45:2331-8.
43. Richard C, Couture P, Desroches S, Lichtenstein AH, Lamarche B. Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome. J Lipid Res. 2013;54:232-7.
44. Richard C, Couture P, Ooi EM, Tremblay AJ, Desroches S, Charest A, et al. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome. Arterioscler Thromb Vasc Biol. 2014;34:433-8.
45. Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Parker T, Faulkner D, et al. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr. 2002;75:834-9.
46. Archer WR, Lamarche B, Deriaz O, Landry N, Corneau L, Despres JP, et al. Variations in body composition and plasma lipids in response to a high-carbohydrate diet. Obes Res. 2003;11:978-86.
47. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 2003;107:499-511.
48. Crichton GE, Bryan J, Buckley J, Murphy KJ. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev: Off J Int Assoc Study Obes. 2011;12:e190-201.
49. Benatar JR, Sidhu K, Stewart RA. Effects of high and low fat dairy food on cardio-metabolic risk factors: a meta-analysis of randomized studies. PLoS One. 2013;8:e76480.
50. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 2005;82:523-30.
51. Huth PJ, Park KM. Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv Nutr. 2012;3:266-85.
52. Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord. 2008;6:87-102.
53. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
54. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146-55.
55. Labonte ME, Couture P, Richard C, Desroches S, Lamarche B. Impact of dairy products on biomarkers of inflammation: a systematic review of randomized controlled nutritional intervention studies in overweight and obese adults. Am J Clin Nutr. 2013;97:706-17.
56. Maes W, Van Camp J, Vermeirssen V, Hemeryck M, Ketelslegers JM, Schrezenmeir J, et al. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul Pept. 2004;118:105-9.
57. Guay V, Lamarche B, Charest A, Tremblay AJ, Couture P. Effect of short-term low and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects. Metabolism. 2012;61:76-83.
58. Drouin-Chartier JP, Gigleux I, Tremblay AJ, Poirier L, Lamarche B, Couture P. Impact of dairy consumption on essential hypertension: a clinical study. Nutr J. 2014;13:83.